Comparative Proteomics and Interactome Analysis of the SARS-CoV-2 Nucleocapsid Protein in Human and Bat Cell Lines.

Comparative Proteomics and Interactome Analysis of the SARS-CoV-2 Nucleocapsid Protein in Human and Bat Cell Lines.

Publication date: Jul 11, 2024

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 and responsible for the global coronavirus pandemic which started in 2019. Despite exhaustive efforts to trace its origins, including potential links with pangolins and bats, the precise origins of the virus remain unclear. Bats have been recognized as natural hosts for various coronaviruses, including the Middle East respiratory coronavirus (MERS-CoV) and the SARS-CoV. This study presents a comparative analysis of the SARS-CoV-2 nucleocapsid protein (N) interactome in human and bat cell lines. We identified approximately 168 cellular proteins as interacting partners of SARS-CoV-2 N in human cells and 196 cellular proteins as interacting partners with this protein in bat cells. The results highlight pathways and events that are both common and unique to either bat or human cells. Understanding these interactions is crucial to comprehend the reasons behind the remarkable resilience of bats to viral infections. This study provides a foundation for a deeper understanding of host-virus interactions in different reservoirs.

Open Access PDF

Concepts Keywords
Bat Animals
Coronaviruses bat cells
Pandemic Cell Line
Pangolins Chiroptera
Proteomics Coronavirus Nucleocapsid Proteins
Coronavirus Nucleocapsid Proteins
COVID-19
Host-Pathogen Interactions
host–virus interactions
human cells
Humans
interactome analysis
nucleocapsid phosphoprotein, SARS-CoV-2
nucleocapsid protein
Phosphoproteins
Phosphoproteins
Protein Interaction Maps
Proteomics
SARS-CoV-2
SARS-CoV-2

Semantics

Type Source Name
disease IDO cell
disease VO Severe acute respiratory syndrome coronavirus 2
disease MESH COVID-19
disease MESH viral infections
disease IDO host
drug DRUGBANK Ibuprofen
disease MESH Infection
disease MESH Middle East respiratory syndrome
drug DRUGBANK Coenzyme M
disease IDO virulence
disease IDO infectivity
disease IDO replication
pathway KEGG Ribosome
disease IDO process
drug DRUGBANK Benzylpenicillin
drug DRUGBANK Streptomycin
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Peracetic acid
drug DRUGBANK Methylergometrine
drug DRUGBANK Amino acids
disease VO ORF
drug DRUGBANK Calcium Phosphate
disease VO manufacturer
drug DRUGBANK Tromethamine
drug DRUGBANK Edetic Acid
drug DRUGBANK Urea
drug DRUGBANK Trypsin
drug DRUGBANK Formic Acid
drug DRUGBANK Flunarizine
disease MESH dissociation
disease VO injection
drug DRUGBANK Methionine
drug DRUGBANK L-Cysteine
drug DRUGBANK Sodium lauryl sulfate
disease VO USA
disease IDO algorithm
disease VO efficiency
disease IDO susceptibility
disease IDO assay
drug DRUGBANK Indoleacetic acid
disease IDO pathogen

Original Article

(Visited 1 times, 1 visits today)